INSIGHTS ON ENTERPRISE SOLUTIONS

• Using Digital Tools In Process Development

  Technology can transform the entire biopharma production process chain. Using integrated process models, machine learning, and genetic algorithms has made production faster and more efficient.

• Accelerating Early Phase Biologics From The Clinic To Commercialization

  Strategic planning in early-phase biologics accelerates clinical progress, reduces risk, and lays the groundwork for scalable, compliant manufacturing and successful commercialization.

• Viral Vector Technology Transfers: A Guide To Success

  Strategic, well-aligned partnerships between sponsors and CDMOs are key to efficient, scalable viral vector technology transfer.

• Streamline Process Development & Scale-Up Of Your Antibody

  Process development bridges early discovery and clinical manufacturing, reducing risk, improving scalability, and aligning biologic programs with regulatory and commercial success from the start.

• Driving Robust Tech Transfer In Biologics: CFD Simulation

  11/12/2025

  Computational Fluid Dynamics simulation is essential for robust biologics tech transfer. See how this predictive tool optimizes critical scale-up processes, reducing risk and expediting time to market.

• Stakeholder-Aligned Design For An Intuitive Manufacturing Process

  11/11/2025

  Achieve intuitive and successful automated cell therapy manufacturing by aligning stakeholder needs with a human-centered design and rigorous, real-world process validation.

• Manufacturing Of CAR-T Cells: Automation And Defined Culture Conditions

  11/11/2025

  The process associated with the manufacture of CAR-T cell therapies presents challenges that immensely impact patient accessibility to these treatments. Reducing manufacturing complexity is key.

• What Researchers Should Look For When Choosing A CLD Partner

  11/7/2025

  A strong track record in compliant saline production and scalable quality is key when selecting a biomanufacturing partner. See how these factors help ensure regulatory alignment and long-term success.